Concepedia
Statistics
Publications
36
Citations
2.6K
H-Index
25
Active since
1985
Affiliations
AstraZeneca (Sweden)(Current)
Masonic Medical Research Laboratory
AstraZeneca (United Kingdom)
Karolinska Institutet
University of Gothenburg
Leif Carlsson is an author at AstraZeneca (Sweden) specializing in medicine, pharmacotherapy, and pharmacology.
Top concepts
MedicinePharmacologyPharmacotherapyCardiologyPhysiologyAnesthesiologyElectrophysiologyCardiovascular DiseaseAnesthesiaHeart Failure
Publications per year
1985–2019
Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic
Luc M. Hondeghem, Leif Carlsson, Göran Duker · Circulation · 2001 · 499 citations
QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit
Leif Carlsson, Olle Almgren, Göran Duker · Journal of Cardiovascular Pharmacology · 1990 · 236 citations
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
Li‐Ming Gan, Maria Lagerström‐Fermér, Leif Carlsson et al. · Nature Communications · 2019 · 209 citations · Full text
Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
Leif Carlsson, Jonathan Clarke, Christopher Yen et al. · Molecular Therapy — Methods & Clinical Development · 2018 · 167 citations · Full text
Electrophysiological Characterization of the Prokinetic Agents Cisapride and Mosapride in Vivo and in Vitro: Implications for Proarrhythmic Potential?
Leif Carlsson, Gregory Amos, Birgit Andersson et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 158 citations
1–5 of 36